Key Dates

Related Announcements

PAR-20-238 - Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Heart, Lung, and Blood Institute ( NHLBI )>

National Institute on Minority Health and Health Disparities (NIMHD)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Office of Behavioral and Social Sciences Research (OBSSR)

Office of Research on Women's Health (ORWH)

Purpose

The purpose of this notice is to inform applicants who plan to submit to Funding Opportunity Announcement (FOA) PAR-20-238 "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)" for the May, 17, 2022 and May 17, 2023 deadlines that, as a result of continuing hardships faced by organizations that serve Native Americans, Letters of Support from community collaborators, Native Hawaiian communities and American Indian or Alaska Native Tribal Governments may be received by NIH as Post Submission Materials as late as August 16, 2022 for the May 17, 2022 receipt date or August 16, 2023 for the May 17, 2023 receipt date. All other application materials, including Letters of Support from collaborators with academic or research organization affiliations, must be received by May 17 receipt date of the year in which the application is submitted. Changes to the funding opportunity announcement are as follows:

Section IV. Application and Submission Information

Currently Reads:

Letters of Support:If the applicant(s) is working with tribes/Tribal governments then Tribal/community resolutions of support, or equivalent documents, should accompany the application.

Revised to Read:

Letters of Support:If the applicant(s) is working with communities, tribes/Tribal governments then Tribal/community resolutions of support, or equivalent documents, should accompany the application. For the May 17, 2022 receipt date, Tribal Resolutions and Letters of Support from community collaborators may be submitted up through August 16, 2022 as post-submission material. For the May 17, 2023 receipt date, Tribal Resolutions and Letters of Support from community collaborators may be submitted up through August 16, 2023 as post-submission material. Note that letters of support from Key Personnel and consultants with academic or research organization affiliations must be submitted by the May 17 receipt date of the year it is submitted by 5:00 PM local time of applicant organization.

Post Submission Materials

Currently Reads:

Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy.

Revised to Read:

Applicants are required to follow the instructions for post-submission materials, as described in the policy. For the May 17, 2022 and the May 17, 2023 receipt date: Letters of Support sent as Post submission materials must be submitted as PDFs by the Authorized Organization Representative (AOR) of the applicant organization. Although the post-submission materials may originate from the PD/PI, Contact PD/PI, or organizational officials, the AOR must send the materials directly to the SRO or must send his/her concurrence to the PD/PI who will forward the materials and concurrence to the SRO. A communication from the PD/PI only or with a "cc" to the AOR will not be accepted. If the Letters of Support are submitted after the May 17th, each letter should contain the following:
Principal Investigator Name:
Principal Investigator email:
Principal Investigator phone number:
Title of the project:
Grant number (if available):

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Kathy Etz, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1749
Email: Ketz@nih.gov

Aria Crump, Sc.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0881
Email: acrump@nida.nih.gov